A global network of non-profit organisations supporting those affected by Niemann-Pick Diseases

Mallinckrodt Reaches Agreement to Divest Experimental Drug Adrabetadex to Mandos, LLC

Company plans to produce up to an additional two years’ supply of drug for eligible patients Agreement is subject...

Cyclo Therapeutics Appoints Lori McKenna Gorski as Global Head of Patient Advocacy

INPDA Spotlight on Fundación Niemann-Pick de España (FNP)

Sometimes in such a big organisation as the INPDA, our various member groups can be overshadowed, but we want...